Author/Authors :
Zumárraga, uan Pablo Universidade de São Paulo - Faculdade de Medicina - Hospital das Clinicas HCFMUSP- Orthopedics and Traumatology Institute - Orthopedic Oncology Group, São Paulo, SP, Brazil , augusto ribeiro batista, FeliPe Universidade de São Paulo - Faculdade de Medicina - Hospital das Clinicas HCFMUSP- Orthopedics and Traumatology Institute - Orthopedic Oncology Group, São Paulo, SP, Brazil , mathias baPtista, andré Universidade de São Paulo - Faculdade de Medicina - Hospital das Clinicas HCFMUSP- Orthopedics and Traumatology Institute - Orthopedic Oncology Group, São Paulo, SP, Brazil , tadeu caiero, marcelo Universidade de São Paulo - Faculdade de Medicina - Hospital das Clinicas HCFMUSP- Orthopedics and Traumatology Institute - Orthopedic Oncology Group, São Paulo, SP, Brazil , Pablo de la rosa martino, luis Universidade de São Paulo - Faculdade de Medicina - Hospital das Clinicas HCFMUSP- Orthopedics and Traumatology Institute - Orthopedic Oncology Group, São Paulo, SP, Brazil , camargo, olavo Pires de Universidade de São Paulo - Faculdade de Medicina - Orthopedics and Traumatology Institute, São Paulo, SP, Brazil
Abstract :
Objective: Myxofibrosarcoma (MFS) is a common soft tissue sar-
coma (STS) that affects the extremities in elderly patients. The
objective was to analyze the prognostic factors and outcomes
of patients with MFS treated at a single institution. Methods: We
retrospectively reviewed the records of 75 patients with MFS. We
compared age, sex, tumor size and location, grade and stage of
the disease. Median age was 49.7 years (range, 1 to 88 y). Location:
upper extremity (25.4%), lower extremity (66.6%) and pelvis (8%).
Patients had high-grade tumors in 46.7% of the reports. Margins
were negative in 76% of the cases. Bivariate Cox regression analysis
was used to determine associations between clinical and treatment
factors with local recurrence (LR). Results: Median follow-up time
was 30.7 months (range, 1.8 to 383.8 m). We found 26.7% of LR.
Distant metastasis (DM) was reported in 27 (36%) patients. Lung was
the most common site of DM, reported in 92.6% of patients. Overall
survival (OS) with metastasis was 21.2 months (range, 4.8 to 114.8
m). Predictors of OS were grade, LR (hazard ratio [HR] 5.13, 95%
confidence interval, 2.15-12.24, P <0.001), and DM (HR 540.97, 95%
confidence interval, 5.04-58112.03, P< 0.001). Conclusions: Tumor
grade, LR, positive margins and DM were significant predictors of
poor OS prognosis. Level of Evidence IV, Case Series.
Keywords :
Sarcoma , Excision margins , Recurrence , Radiotherapy , Neoplasm metastasis